Medical Cannabis
Science-led insight on therapeutic use, formulations, and clinical best practice.
Medical Cannabis · page 5
- Industry Trends
Germany’s Medical Cannabis Product Range Quadruples as Prices Fall 30%
Business of Cannabis is excited to announce the launch of German Cannabis Intel: Insights & Market Data, the inaugural report in our new quarterly series in partnership with Grünhorn.
- Industry Trends
Is the German Cannabis Boom Slowing Down, or Simply Normalising?
Germany’s cannabis imports, according to the latest figures from BfArM, nearly tripled in size in 2025, cementing it beyond any doubt as the engine behind Europe’s medical cannabis boom.
- Medical Cannabis
Why Medical Cannabis Clinics Should Be Knocking on Union Doors
When a crew trainer at a fast food restaurant told her manager she had recently been prescribed medical cannabis, she came prepared.
- Industry Trends
Germany’s Post-CanG Import Surge Loses Steam as Q4 Growth Stalls
Germany’s imports for 2025 surpassed 200 tonnes for the first time, exceeding the country’s already revised import quota for the second time in a year.
- Industry Trends
The Scramble for Europe
Last month, the German cannabis market saw its most significant consolidation deal to date, as Canadian heavyweight Organigram announced plans to acquire Sanity Group in a deal worth up to €250m.
- Industry Trends
New Report: Poland Medical Cannabis Market Data Shows Full Post-Ban recovery, With a Catch
Polish pharmacies dispensed nearly 5,450 kilograms of dried cannabis flower in 2025, a 12% increase from the prior year, according to new data obtained by Prohibition Partners.
- Medical Cannabis
Cannabis Europa Paris 2026: France’s Medical Cannabis Reimbursement Plans Revealed
Today (February 19, 2026), Cannabis Europa returns to the French capital for the first time since 2019 at a critical juncture for the incoming French medical cannabis industry.
- Industry Trends
Access, Saturation, Consolidation: Why Denmark Foreshadows the Future of Europe’s Medical Cannabis Markets
As Europe’s medical cannabis markets continue to mature, an increasingly familiar pattern is beginning to emerge.
- Medical Cannabis
France’s Long-Awaited Medical Cannabis Reimbursement Framework to Be Revealed Next Week
French authorities will present a first draft of the long-awaited pricing and reimbursement decree for medical cannabis on February 18, marking a critical milestone in the country’s drawn-out transition from pilot programme to permanent framework.
- Investment & Finance
French Excellence at the Heart of a High-Capacity EU-GMP Site
PGP Farmer closes a €3m funding round to become a leading player in EU-GMP medical cannabis production in Europe French biotech company PGP Farmer unveils the closing of a €3 million funding round with private investors.
- Medical Cannabis
Medical Cannabis Police Guidance Published, But No Training Programme Planned
Medical cannabis once again found itself at the centre of the UK mainstream media’s attention this week, following a troubling coroner’s finding that a prescription ‘contributed to’ a patient’s death.
- Cultivation
Future-Ready: Why Pure Is Building the Cannabis Company Traditional Industry Will Want to Buy Into
Last year, as other European cannabis markets looked to be retreating from their ambitious progress in 2024, Switzerland accelerated its plans for cannabis reform.
